ADRENALIGNE
ActiveSummary
The annual accounts of ADRENALIGNE for financial year 2025 show a net loss of 648% of total assets and of 93% of the equity at the start of that year. The 2025 annual accounts show equity of €278,374 and a net result of -€3.8m. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 52% of 318 sector peers (NACE 58, financial year 2025). The company has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.2% (very low).
Directors
Directors
No directors read yet: 1 of 6 Gazette acts processed. See the directors and other office holders in the KBO →
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.